What is Range Biotechnologies?
Founded in 2022, Range Biotechnologies is a biotechnology company specializing in proteomics, a field dedicated to the large-scale study of proteins. Headquartered in San Francisco, California, the company is positioned at the forefront of innovation within the health tech and biopharma industries. Its focus on proteomics suggests a commitment to advancing diagnostic and therapeutic solutions through a deeper understanding of cellular functions and disease mechanisms. The company's recent major enterprise-level funding indicates strong market confidence in its technological approach and future prospects.
How much funding has Range Biotechnologies raised?
Range Biotechnologies has raised a total of $5.2M across 1 funding round:
Angel/Seed
$5.2M
Angel/Seed (2023): $5.2M with participation from Civilization Ventures, Pear VC, Page One Ventures, and ARTIS Ventures
Key Investors in Range Biotechnologies
Civilization Ventures
Civilization Ventures is a venture capital firm focused on health tech and biopharma, investing in companies that advance preventative, personalized, and regenerative healthcare. They have a strong track record of supporting early-stage innovators.
Pear VC
Pear VC is an early-stage investment firm specializing in pre-seed and seed funding, providing comprehensive support to founders in building and scaling innovative companies.
ARTIS Ventures
ARTIS Ventures is a venture capital fund dedicated to Tech Bio+Health, investing in data-driven life sciences companies aiming to improve human health through innovative technologies.
What's next for Range Biotechnologies?
With substantial backing, Range Biotechnologies is poised for significant expansion. The strategic investment will likely fuel further research and development, potentially leading to the commercialization of novel proteomics-based tools or therapies. The company's trajectory suggests a move towards scaling its operations, enhancing its market presence, and possibly forging strategic partnerships within the biotechnology ecosystem. Continued investment in this area signals a growing trend towards data-driven health solutions and personalized medicine.
See full Range Biotechnologies company page
